Ellie Guardino

Ellie Guardino has extensive experience in oncology, having held various leadership positions at Genentech from September 2010 to August 2016, including Vice President of Personalized Health Care Oncology and Senior Group Medical Director for Product Development Oncology, where responsibilities included leading teams for the HER2 Franchise and developing strategic initiatives for breast cancer. Prior roles at Genentech involved clinical development of T-DM1, where Ellie served as Clinical Science Lead and Global Clinical Filing Lead. In addition, Ellie Guardino has been an Assistant Professor of Medicine at Stanford University since January 2000, contributing to academic medicine as adjunct clinical faculty. Ellie Guardino completed a fellowship in oncology at Stanford University Medical School and an internship and residency in medicine at Harvard University Medical School.